NIFTY 50

Pfizer-Mylan deal will not impact Biocon's business, says CMD Kiran Mazumdar Shaw

Updated : July 30, 2019 08:57 AM IST

Had indicated looking at pursuing biosimilar opportunity independently: Shaw
Pfizer's biosimilar portfolio is not parked with Upjohn: Shaw
primo org
Have you signed up for Primo, our daily newsletter?
It has all the stories and data on the market, business, economy and tech that you need to know.
cnbc two logos
To keep watching CNBC-TV18, India's No. 1 English Business News Channel, call your Cable or DTH Operator and subscribe now for just Rs. 4 per month. You can also subscribe to CNBC-TV18 Prime HD for Re 1/- per month.Find out more

You May Also Like

Live TV